FDA label
What is lacosamide used for?
The FDA-approved uses of lacosamide, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label for lacosamide (tablet, film coated) lists 2 uses: Partial-Onset Seizures; Primary Generalized Tonic-Clonic Seizures.
Run it in Rivvi
Which 2027 plans near you dropped or restricted lacosamide?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Lacosamide, tablet, film coated
Indications and Usage, quoted from the label by Camber Pharmaceuticals, Inc. (ANDA204787). Cross-references to other label sections are left out.
Partial-Onset Seizures
Lacosamide tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older.
Primary Generalized Tonic-Clonic Seizures
Lacosamide tablets are indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older.
Source: DailyMed label, set id c5b91128-f838-4e98-9684-5f477fc7af06, version 7, effective June 22, 2026. NDC 31722-812, one of 87 listings for this product.
Lacosamide, tablet
Indications and Usage, quoted from the label by Amneal Pharmaceuticals of New York LLC (ANDA204857). Cross-references to other label sections are left out.
Partial-Onset Seizures
Lacosamide tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
Primary Generalized Tonic-Clonic Seizures
Lacosamide is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older.
Additional pediatric use information is approved for UCB, Inc.’s VIMPAT® (lacosamide) tablets. However, due to UCB, Inc.’s marketing exclusivity rights, this drug product is not labeled with that information.
Source: DailyMed label, set id 0e21389b-2f51-4975-aa21-fc5c9dd9f6dc, version 3, effective May 17, 2024. NDC 53746-923, one of 22 listings for this product.
Questions
What is lacosamide used for?
The FDA label for lacosamide (tablet, film coated) lists 2 uses: Partial-Onset Seizures; Primary Generalized Tonic-Clonic Seizures.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Lacosamide
- Is Lacosamide a controlled substance?Schedule V
- Generic for Motpoly XRFDA Orange Book
- Generic for VimpatFDA Orange Book
- What is Vimpat used for?FDA label uses
- Is Vimpat a controlled substance?Schedule V
- What is Motpoly XR used for?FDA label uses
- Is Motpoly XR a controlled substance?Schedule V
- NDC 0131-1810Lacosamide NDC record
- NDC 0131-2477Lacosamide NDC record
- NDC 0131-2478Lacosamide NDC record
- Schedule V drugs listDEA schedule